These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1037 related articles for article (PubMed ID: 27349336)

  • 21. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB
    Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional study.
    Matharu M; Katsarava Z; Buse DC; Sommer K; Reed ML; Fanning KM; Lipton RB
    Headache; 2024; 64(7):750-763. PubMed ID: 38982663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Seng EK; Chu MK; Reed ML; Fanning KM; Adams AM; Buse DC
    Headache; 2020 Sep; 60(8):1683-1696. PubMed ID: 33448374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study.
    Buse DC; Powers SW; Gelfand AA; VanderPluym JH; Fanning KM; Reed ML; Adams AM; Lipton RB
    Headache; 2018 Apr; 58(4):512-524. PubMed ID: 29355924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
    Hutchinson S; Lipton RB; Ailani J; Reed ML; Fanning KM; Adams AM; Buse DC
    Mayo Clin Proc; 2020 Apr; 95(4):709-718. PubMed ID: 32247344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of migraine related to menses: results from the AMPP study.
    Pavlović JM; Stewart WF; Bruce CA; Gorman JA; Sun H; Buse DC; Lipton RB
    J Headache Pain; 2015 Mar; 16():24. PubMed ID: 25902814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.
    Lipton RB; Serrano D; Holland S; Fanning KM; Reed ML; Buse DC
    Headache; 2013 Jan; 53(1):81-92. PubMed ID: 23078241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracing transformation: chronic migraine classification, progression, and epidemiology.
    Lipton RB
    Neurology; 2009 Feb; 72(5 Suppl):S3-7. PubMed ID: 19188564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results.
    Adams AM; Serrano D; Buse DC; Reed ML; Marske V; Fanning KM; Lipton RB
    Cephalalgia; 2015 Jun; 35(7):563-78. PubMed ID: 25304766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
    Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study.
    Lanteri-Minet M; Leroux E; Katsarava Z; Lipton RB; Sakai F; Matharu M; Fanning K; Manack Adams A; Sommer K; Seminerio M; Buse DC
    J Headache Pain; 2024 Aug; 25(1):134. PubMed ID: 39160483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns.
    Ford JH; Jackson J; Milligan G; Cotton S; Ahl J; Aurora SK
    Headache; 2017 Nov; 57(10):1532-1544. PubMed ID: 28984356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML
    Headache; 2013; 53(10):1548-63. PubMed ID: 23992516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Dodick DW; Loder EW; Manack Adams A; Buse DC; Fanning KM; Reed ML; Lipton RB
    Headache; 2016 May; 56(5):821-834. PubMed ID: 27143127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Buse DC; Saiers J; Fanning KM; Serrano D; Reed ML
    Headache; 2013 Jan; 53(1):93-103. PubMed ID: 23148774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.
    Bigal ME; Rapoport AM; Lipton RB; Tepper SJ; Sheftell FD
    Headache; 2003 Apr; 43(4):336-42. PubMed ID: 12656704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
    Adams AM; Buse DC; Leroux E; Lanteri-Minet M; Sakai F; Matharu MS; Katsarava Z; Reed ML; Fanning K; Sommer K; Lipton RB
    Cephalalgia; 2023 Jun; 43(6):3331024231180611. PubMed ID: 37314231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies.
    Smitherman TA; Burch R; Sheikh H; Loder E
    Headache; 2013 Mar; 53(3):427-36. PubMed ID: 23470015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.